Secologanin vs Linuron
Mechanistic comparison of Secologanin Tryptamine Alkaloids Compounds formed by condensation of secologanin with tryptamine resulting in and Linuron based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
8
Shared Targets
38%
Jaccard Similarity
37%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
Secologanin and Linuron share 8 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.381 means 38% of the combined target set is bound by both compounds. The IDF-weighted score of 0.368 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.